文献速递临床试验与 GCP流行病学与生物统计

妇女健康倡议随机试验与临床实践:综述

The Women's Health Initiative Randomized Trials and Clinical Practice: A Review.
PubMed 文献 · JAMA · 2024-01-01

该综述基于妇女健康倡议(WHI)随机临床试验(1993至1998年入组161 808名50至79岁绝经后女性,随访长达20年),总结绝经激素治疗、钙加维生素D补充及低脂膳食模式的健康效应。WHI结果不支持用口服结合马雌激素加醋酸甲羟孕酮或单用结合马雌激素预防心血管疾病、痴呆或其他慢性病,但激素治疗对缓解中重度血管舒缩症状有效。

要点

  • WHI结果不支持绝经激素治疗用于预防心血管疾病、痴呆或其他慢性病。
  • 激素治疗对治疗中重度血管舒缩症状及其他绝经症状有效。
  • 无禁忌证的早期绝经女性有困扰性症状可在60岁前启动激素治疗。

核心结论

  • WHI随机临床试验不支持绝经激素治疗用于预防心血管疾病或其他慢性病。
  • 激素治疗适用于无禁忌证、有困扰性血管舒缩症状且有意愿使用的早期绝经女性。
  • WHI证据不支持常规补充钙加维生素D以预防骨折,也不支持通过增加果蔬和谷物的低脂膳食预防乳腺癌或结直肠癌。
  • 低脂膳食模式可能降低乳腺癌死亡率这一次要结局,原文指出这需要进一步研究。

研究设计与样本

  • WHI于1993至1998年在美国入组161 808名基线50至79岁绝经后女性,其中68 132名参与随机临床试验,随访长达20年。

主要发现

  • WHI临床试验结果不支持口服结合马雌激素加醋酸甲羟孕酮用于绝经后女性,或单用结合马雌激素用于子宫切除后女性,以预防心血管疾病、痴呆或其他慢性病。
  • 激素治疗对治疗中重度血管舒缩症状及其他绝经症状有效。
  • 早期绝经使用激素治疗的获益,结合早期较晚期的激素治疗不良效应发生率更低,支持无禁忌证且有困扰性绝经症状的女性在60岁前启动激素治疗。
  • WHI结果不支持对所有绝经后女性常规推荐钙加维生素D补充以预防骨折。
  • 增加水果、蔬菜和谷物摄入的低脂膳食模式未预防乳腺癌或结直肠癌主要结局,但在长期随访中与乳腺癌死亡率次要结局的较低发生率相关。

关键数值与推荐

  • 激素治疗适用于无禁忌证、有困扰性血管舒缩症状的早期绝经女性,原文支持在60岁前启动。
  • 钙和维生素D适用于通过膳食未达到国家指南推荐摄入量的女性。
  • WHI证据不支持对所有绝经后女性常规推荐钙加维生素D补充以预防骨折。
  • WHI证据不支持通过增加果蔬和谷物的低脂膳食预防乳腺癌或结直肠癌。

临床怎么用

  • 对有困扰性血管舒缩症状的早期绝经女性,若无禁忌证且有意愿,可在60岁前启动激素治疗。
  • 钙和维生素D适用于膳食摄入未达国家指南推荐量的女性。
  • 不常规推荐所有绝经后女性补充钙加维生素D以预防骨折。
  • 不推荐通过增加果蔬和谷物的低脂膳食预防乳腺癌或结直肠癌。

局限性

  • 低脂膳食模式可能降低乳腺癌死亡率这一次要结局,原文指出需要进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Approximately 55 million people in the US and approximately 1.1 billion people worldwide are postmenopausal women. To inform clinical practice about the health effects of menopausal hormone therapy, calcium plus vitamin D supplementation, and a low-fat dietary pattern, the Women's Health Initiative (WHI) enrolled 161 808 postmenopausal US women (N = 68 132 in the clinical trials) aged 50 to 79 years at baseline from 1993 to 1998, and followed them up for up to 20 years. OBSERVATIONS: The WHI clinical trial results do not support hormone therapy with oral conjugated equine estrogens plus medroxyprogesterone acetate for postmenopausal women or conjugated equine estrogens alone for those with prior hysterectomy to prevent cardiovascular disease, dementia, or other chronic diseases. However, hormone therapy is effective for treating moderate to severe vasomotor and other menopausal symptoms. These benefits of hormone therapy in early menopause, combined with lower rates of adverse effects of hormone therapy in early compared with later menopause, support initiation of hormone therapy before age 60 years for women without contraindications to hormone therapy who have bothersome menopausal symptoms. The WHI results do not support routinely recommending calcium plus vitamin D supplementation for fracture prevention in all postmenopausal women. However, calcium and vitamin D are appropriate for women who do not meet national guidelines for recommended intakes of these nutrients through diet. A low-fat dietary pattern with increased fruit, vegetable, and grain consumption did not prevent the primary outcomes of breast or colorectal cancer but was associated with lower rates of the secondary outcome of breast cancer mortality during long-term follow-up. CONCLUSIONS AND RELEVANCE: For postmenopausal women, the WHI randomized clinical trials do not support menopausal hormone therapy to prevent cardiovascular disease or other chronic diseases. Menopausal hormone therapy is appropriate to treat bothersome vasomotor symptoms among women in early menopause, without contraindications, who are interested in taking hormone therapy. The WHI evidence does not support routine supplementation with calcium plus vitamin D for menopausal women to prevent fractures or a low-fat diet with increased fruits, vegetables, and grains to prevent breast or colorectal cancer. A potential role of a low-fat dietary pattern in reducing breast cancer mortality, a secondary outcome, warrants further study.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Manson JE, Crandall CJ, Rossouw JE, et al. The Women's Health Initiative Randomized Trials and Clinical Practice: A Review. JAMA. 2024. PMID: 38691368. doi:10.1001/jama.2024.6542

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。